Gautam Gopalji Jha MD
Assistant Professor, Medicine, University of Minnesota Medical School, Minneapolis
Telehealth Available
Request Appointment909 Fulton Street, Masonic Cancer CenterMasonic Cancer Center, Division of Hematology, Oncology and Transplant (Dept Of Medicine)Minneapolis, MN 55455
Overview of Dr. Jha
Dr. Gautam Jha is an oncologist in Minneapolis, MN and is affiliated with multiple hospitals in the area, including M Health Fairview University of Minnesota Medical Center, M Health Fairview Southdale Hospital, M Health Fairview Ridges Hospital, M Health Fairview Lakes Medical Center, and M Health Fairview Northland Medical Center. He received his medical degree from Terna Medical College and has been in practice 19 years. He is one of 21 doctors at M Health Fairview Lakes Medical Center and one of 85 doctors at M Health Fairview University of Minnesota Medical Center who specialize in Oncology. He has more than 10 publications and over 200 citings.
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 2007 - 2010
University of TennesseeResidency, Internal Medicine, 2005 - 2007
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Internal Medicine, 2004 - 2005
Terna Medical CollegeClass of 1998
Certifications & Licensure
MN State Medical License 2007 - 2025
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Everolimus Versus Placebo in Head and Neck Cancer Start of enrollment: 2010 Apr 01
- Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity Start of enrollment: 2010 Dec 01
- Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer Start of enrollment: 2012 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsAdjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274.Matthew D Galsky, Johannes Alfred Witjes, Jürgen E Gschwend, Matthew I Milowsky, Michael Schenker
Journal of Clinical Oncology. 2025-01-01 - Clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with abiraterone with or without ongoing androgen deprivation therapy: A retro...Ali T Arafa, Leah R Blader, Karan Ramakrishna, Jeff Engle, Charles J Ryan
The Prostate. 2023-09-01 - 7 citationsA Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck.Cherie-Ann O Nathan, D Neil Hayes, Theodore Karrison, Olivier Harismendy, José M Flores
Clinical Cancer Research. 2022-12-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
